Michael R. Megna, Chief Accounting Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 25/10/22

Trade details

Type: Insider sale
Amount: $1,442,513.6
Shares · price: 37,255 sh · $38.72 a share
Held after: 40,281 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: Michael R. MegnaChief Accounting Officer
Trade date: 25/10/20
Filed: 25/10/22
Days to filing: 2 days

Sold 48.0% of holdings

Share of holding sold: 48.0%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 25/09/20~25/11/19

Michael R. Megna's recent trades

Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$369.4K
4,600 sh
$369.4K
Filed 09/03
Traded 09/03
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/13
Traded 04/09
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/09
Traded 04/09
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$520.3K
13,235 sh
$520.3K
Filed 25/10/22
Traded 25/10/20
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$2M
50,490 sh
$2M
Filed 25/10/20
Traded 25/10/20

Michael R. Megna, CAO — sold $1.4M of Kiniksa Pharmaceuticals International KNSA · 48.0% of holdings · 10b5-1 plan | Whalegun